Literature DB >> 12215457

Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization.

Mei Zhang1, Shouhong Xuan, Mary L Bouxsein, Dietrich von Stechow, Nagako Akeno, Marie Claude Faugere, Hartmut Malluche, Guisheng Zhao, Clifford J Rosen, Argiris Efstratiadis, Thomas L Clemens.   

Abstract

To examine the local actions of IGF signaling in skeletal tissue in a physiological context, we have used Cre-mediated recombination to disrupt selectively in mouse osteoblasts the gene encoding the type 1 IGF receptor (Igf1r). Mice carrying this bone-specific mutation were of normal size and weight but, in comparison with normal siblings, demonstrated a striking decrease in cancellous bone volume, connectivity, and trabecular number, and an increase in trabecular spacing. These abnormalities correlated with a striking decrease in the rate of mineralization of osteoid that occurred despite an unexpected osteoblast and osteoclast hyperactivity, detected from the significant increments in both osteoblast and erosion surfaces. Our findings indicate that IGF1 is essential for coupling matrix biosynthesis to sustained mineralization. This action is likely to be particularly important during the pubertal growth spurt when rapid bone formation and consolidation are required.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12215457     DOI: 10.1074/jbc.M208265200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  309 in total

Review 1.  The role of circulating IGF-I: lessons from human and animal models.

Authors:  Shoshana Yakar; Yiping Wu; Jennifer Setser; Clifford J Rosen
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

2.  Serum insulin-like growth factor-I is a marker for assessing the severity of vertebral fractures in postmenopausal women with type 2 diabetes mellitus.

Authors:  I Kanazawa; T Yamaguchi; T Sugimoto
Journal:  Osteoporos Int       Date:  2010-06-08       Impact factor: 4.507

3.  Connective tissue growth factor is required for skeletal development and postnatal skeletal homeostasis in male mice.

Authors:  Ernesto Canalis; Stefano Zanotti; Wesley G Beamer; Aris N Economides; Anna Smerdel-Ramoya
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

Review 4.  Building strong bones: molecular regulation of the osteoblast lineage.

Authors:  Fanxin Long
Journal:  Nat Rev Mol Cell Biol       Date:  2011-12-22       Impact factor: 94.444

Review 5.  MicroRNA control of bone formation and homeostasis.

Authors:  Jane B Lian; Gary S Stein; Andre J van Wijnen; Janet L Stein; Mohammad Q Hassan; Tripti Gaur; Ying Zhang
Journal:  Nat Rev Endocrinol       Date:  2012-01-31       Impact factor: 43.330

Review 6.  The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis.

Authors:  John A Arnott; Alex G Lambi; Christina Mundy; Honey Hendesi; Robin A Pixley; Thomas A Owen; Fayez F Safadi; Steven N Popoff
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

Review 7.  Signaling pathways affecting skeletal health.

Authors:  Pierre J Marie
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

Review 8.  Update in new anabolic therapies for osteoporosis.

Authors:  Ernesto Canalis
Journal:  J Clin Endocrinol Metab       Date:  2010-04       Impact factor: 5.958

9.  Insulin-like growth factor-1 increases bone calcium accumulation only during rapid growth in female rats.

Authors:  Qinmin Zhang; Meryl E Wastney; Clifford J Rosen; Wesley G Beamer; Connie M Weaver
Journal:  J Nutr       Date:  2011-09-28       Impact factor: 4.798

10.  GATA4 represses RANKL in osteoblasts via multiple long-range enhancers to regulate osteoclast differentiation.

Authors:  Aysha B Khalid; Alexandria V Slayden; Jerusha Kumpati; Chanel D Perry; Stuart B Berryhill; Julie A Crawford; Iram Fatima; Marco Morselli; Matteo Pellegrini; Gustavo A Miranda-Carboni; Susan A Krum
Journal:  Bone       Date:  2018-07-19       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.